White, D.
MacDonald, S.
Bull, T.
Hayman, M.
de Monteverde-Robb, R.
Sapsford, D.
Lavinio, A.
Varley, J.
Johnston, A.
Besser, M.
Thomas, W. http://orcid.org/0000-0001-6969-3173
Article History
First Online: 22 May 2020
Change Date: 22 June 2020
Change Type: Correction
Change Details: In the original publication of this article, one of the co-author name "D. de Monteverde-Robb" was inadvertently mentioned as "R. de Monteverde-Robb". The correct author name is "D. de Monteverde-Robb". This error has been corrected with this erratum.
Compliance with ethical standards
:
: MB—speakers fee STAGO, Advisory board Novartis, Cosmopharma, Werfen. WT—speakers fees from Pfizer, Bayer, Takeda and advisory boards for Daiichi-Sankyo, Sanofi and Ablynx. No other authors declared relevant conflicts of interest.
: This study had institutional research and ethics approval. As this was a retrospective study patient consent was not deemed necessary.
Free to read: This content has been made available to all.